| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/22/2014 | CN103520228A Application of mango crude extracts to preparation of drugs and food for controlling cardiovascular diseases |
| 01/22/2014 | CN103520223A GMP (Good Manufacturing Practice) production process of refined fine-powder bag-brewing type ginkgo leaf product and application method thereof |
| 01/22/2014 | CN103520221A Process for producing medical dried yeast powder |
| 01/22/2014 | CN103520200A Composition containing ophiopogon japonicus polysaccharide MDG-1 and application of composition in preparation of medicament or healthcare product for improving metabolic syndromes |
| 01/22/2014 | CN103520199A Application of lycium barbarum polysaccharide in diabetes treating medicine |
| 01/22/2014 | CN103520197A Anticonnexin polynucleotides as impaired wound healing compositions |
| 01/22/2014 | CN103520193A Pharmaceutical composition and preparation method thereof |
| 01/22/2014 | CN103520192A Invert sugar freeze-dried powder preparation for injection and preparation method thereof |
| 01/22/2014 | CN103520186A Pharmaceutical composition comprising lipid-soluble vitamin for injection and preparation method of pharmaceutical composition |
| 01/22/2014 | CN103520183A Application of phyllanthoid A in preparing medicament for reducing blood sugar |
| 01/22/2014 | CN103520158A Contains pioglitazone oral formulation |
| 01/22/2014 | CN103520156A Compound alpha-ketoacid tablet free of talcum powder and preparation process thereof |
| 01/22/2014 | CN103520114A Nuciferine microsphere and preparation method thereof |
| 01/22/2014 | CN103520102A Vitamin D nano-emulsion and preparation method thereof |
| 01/22/2014 | CN103519851A Manufacturing method for sunken cord fatness reduction line |
| 01/22/2014 | CN103519291A Orange juice |
| 01/22/2014 | CN103519288A Grape juice |
| 01/22/2014 | CN103519238A Health-care camel meat ball |
| 01/22/2014 | CN103519237A Health-care otter meat food |
| 01/22/2014 | CN103519217A Health-care goose meatballs |
| 01/22/2014 | CN103519205A Food made of bamboo rat meat |
| 01/22/2014 | CN103519193A Health-care rabbit meat ball |
| 01/22/2014 | CN103519192A Frog meat food |
| 01/22/2014 | CN103519179A Health care potato chips |
| 01/22/2014 | CN103519174A Slimming healthcare product |
| 01/22/2014 | CN103519163A Multifunctional health care product composition |
| 01/22/2014 | CN103519146A Flammulina velutipes oral liquid |
| 01/22/2014 | CN103519036A Jelly |
| 01/22/2014 | CN103518919A Coffee |
| 01/22/2014 | CN103518917A Murraya tetramera Huang tea with health-care functions and preparation method |
| 01/22/2014 | CN103518910A Pine needle tea drink |
| 01/22/2014 | CN103025705B Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same |
| 01/22/2014 | CN103007002B Traditional Chinese medicine lipid-lowering soup for treating hyperlipidemia |
| 01/22/2014 | CN103006643B Compound injection containing 18 amino acids and preparation method thereof |
| 01/22/2014 | CN102847164B Application of chrysalis oil in improving small molecule drug bioavailability |
| 01/22/2014 | CN102824391B Application of kalimeris in preparation of medicament for reducing blood fat or functional foods |
| 01/22/2014 | CN102753540B A4ss2 neuronal nicotinic acetylcholine receptor ligands |
| 01/22/2014 | CN102488889B Caspofungin preparation with low impurity content and preparation method and application thereof |
| 01/22/2014 | CN102302539B Method for producing trifolium pratense L. isoflavones |
| 01/22/2014 | CN102266429B Mixture of sea buckthorn seed extract and camellia oil, and preparation method thereof |
| 01/22/2014 | CN102231986B Use of phytoecdysones in the preparation of a composition for acting on metabolic syndrome |
| 01/22/2014 | CN101869172B Production method of active eel peptide |
| 01/22/2014 | CN101772487B Thyroid compounds |
| 01/22/2014 | CN101678055B Supplemention of maternal diet |
| 01/22/2014 | CN101503409B 8-(3-amino-piperidin-1-yl)-xanthines, the production thereof and the use of the same as medicaments |
| 01/21/2014 | US8633210 Triazole compounds useful as protein kinase inhibitors |
| 01/21/2014 | US8633199 Medicine consisting of concomitant use or combination of DPP-IV inhibitor and other diabetic medicine |
| 01/21/2014 | US8633184 Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol |
| 01/21/2014 | US8633175 Compounds as antagonists or inverse agonists at opioid receptors |
| 01/21/2014 | US8633153 Transthyretin variants |
| 01/21/2014 | US8632824 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors, biofilters and bioreactors |
| 01/21/2014 | US8632803 System for delivery of protein in insoluble fibrillar or aggregate form |
| 01/21/2014 | CA2806698C Dietary supplement and methods of use thereof |
| 01/21/2014 | CA2789001C Method for treatment of lacto-n-biose-containing solution |
| 01/21/2014 | CA2722600C Anti-hepcidin antibodies and methods of use |
| 01/21/2014 | CA2452354C Pet food composition for regulating body weight and preventing obesity and related disorders in pets |
| 01/21/2014 | CA2371995C Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 01/19/2014 | CA2785303A1 Method for the non-surgical treatment of lipodystrophy in a retrovirus-infected individual |
| 01/16/2014 | WO2014011926A1 Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk |
| 01/16/2014 | WO2014011814A1 Tri-salt form of metformin |
| 01/16/2014 | WO2014011742A1 Method and composition for metabolic regulation |
| 01/16/2014 | WO2014011461A1 Amide or urea substituted benzothiazole derivatives as inhibitors of endothelial lipase |
| 01/16/2014 | WO2014011085A1 Agent exhibiting antioxidant, anti-inflammatory, neuroprotective, hypolipidemic, hypocholesterolemic, hypoglycemic, hepatoprotective and immunosuppressive activities |
| 01/16/2014 | WO2014010985A1 Peptide for highly efficient introduction and maintenance of intracellular protein |
| 01/16/2014 | WO2014010746A1 Brown fat cells and method for preparing same |
| 01/16/2014 | WO2014009860A1 Novel therapy in the treatment of alkaptonuria |
| 01/16/2014 | WO2014009316A1 Novel use of insulin derivatives |
| 01/16/2014 | WO2014009305A1 Inhibitors of phosphodiesterase 10 enzyme |
| 01/16/2014 | WO2014008567A1 Modified peptide, cb receptor ligand, kit, in vitro process for evaluating cb receptor bonds, uses, pharmaceutical composition for modulating cb receptor activity |
| 01/16/2014 | WO2013179308A3 A composition with anti hyperglycemic and antioxidant activity obtained from the extract of parts of coconut and a method of producing the same |
| 01/16/2014 | WO2013177432A9 Methods of treating obesity |
| 01/16/2014 | WO2013136193A3 Methods and compositions for modulating toso activity |
| 01/16/2014 | US20140017282 Use of whey permeate for the treatment of metabolic syndrome |
| 01/16/2014 | US20140017258 Compositions against bacterial toxins |
| 01/16/2014 | CA2875057A1 Inhibitors of phosphodiesterase 10 enzyme |
| 01/15/2014 | EP2684878A1 Dipyridylamine derivative |
| 01/15/2014 | EP2684861A2 Spiro compounds and pharmaceutical use thereof |
| 01/15/2014 | EP2684566A1 Pharmaceutical composition for preventing and treating complications of diabetes containing a traditional oriental medicine extract or a fraction thereof as an active ingredient |
| 01/15/2014 | EP2683742A1 Npp1 fusion proteins |
| 01/15/2014 | EP2683720A1 1H-PYROLLO[3,2-d]PYRIMIDINEDIONE DERIVATIVES |
| 01/15/2014 | EP2683706A1 Oxaspiro [2.5]octane derivatives and analogs |
| 01/15/2014 | EP2683704A1 Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| 01/15/2014 | EP2683703A1 Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
| 01/15/2014 | EP2683702A1 Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
| 01/15/2014 | EP2683701A1 Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| 01/15/2014 | EP2683700A1 Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| 01/15/2014 | EP2683699A1 Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| 01/15/2014 | EP2683698A1 Benzyl-oxathiazine derivates substituted with adamantane or noradamantane, medicaments containing said compounds and use thereof |
| 01/15/2014 | EP2683697A1 Substituted morpholines as modulators for the calcium sensing receptor |
| 01/15/2014 | EP2683690A1 Quinolinone derivatives |
| 01/15/2014 | EP2683444A1 Tfeb phosphorylation inhibitors and uses thereof |
| 01/15/2014 | EP2683393A2 Tripeptide compositions and methods for treatment of diabetes |
| 01/15/2014 | EP2683382A2 Dosing regimens for the treatment of fabry disease |
| 01/15/2014 | EP2683374A1 Use of vanadium compounds for maintaining normaglycemia in a mammal |
| 01/15/2014 | EP2683371A1 Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors |
| 01/15/2014 | EP2683256A1 Nutraceutical composition for limiting the absorption of dietary lipids and for inducing weight loss, comprising, as active agent, at least one extract of carrot |
| 01/15/2014 | CN103517982A Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, method for producing same, and cell therapy and medical therapy therefor |
| 01/15/2014 | CN103517908A Sesterterpene compounds and use thereof |
| 01/15/2014 | CN103517901A 1,4-oxazepines as bace1 and/or bace2 inhibitors |
| 01/15/2014 | CN103517898A Novel 3-hydroxyisothiazole 1-oxide derivative |